Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PIK-93
Cat. No.:
OB0225LY-0088
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
PIK-93 is a PI3K inhibitor that selectively inhibits certain types of phosphatidylinositol 3-kinase (PI3K).
Synonym:
PIK 93; 593960-11-3; N-(5-(4-Chloro-3-(N-(2-hydroxyethyl)sulfamoyl)phenyl)-4-methylthiazol-2-yl)acetamide; N-[5-[4-Chloro-3-(2-hydroxyethylsulfamoyl)phenyl]-4-methyl-1,3-thiazol-2-yl]acetamide; N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide; N-(5-(4-Chloranyl-3-(2-hydroxyethylsulfamoyl)phenyl)-4-methyl-1,3-thiazol-2-yl)ethanamide; Acetamide, N-[5-[4-chloro-3-[[(2-hydroxyethyl)amino]sulfonyl]phenyl]-4-methyl-2-thiazolyl]-; N-[(2Z)-5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2(3H)-ylidene]acetamide
CAS No.:
593960-11-3
Compound CID:
6852167
Formula:
C14H16ClN3O4S2
Formula Weight:
389.88
Specification
Relative Density:
1.48 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
PIK-93 is mainly used in cancer research, especially in stopping tumor cell proliferation and migration.
Library Information
Targets:
PIK; PI3K-like kinases (PIKK)
Receptors:
ATM; C2β; DNA-PK; hsVps34; mTORC1; p110α; p110β; p110γ; p110δ; PI3K; PI3KIIIβ; PI4K; Virus protease
Pathways:
PI3K/Akt/mTOR signaling; Metabolism; Microbiology/Virology; DNA damage/DNA repair
Plate Number:
AOCL-2
Plate Location:
a11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
39 mg/mL; 100 mM
ALogP:
1.076
HBA_Count:
4
HBD_Count:
3
Rotatable Bond:
6
